Skip to main content

Table 2 P-values for associations between metabolites and selecteda variables

From: Lifestyle correlates of eight breast cancer-related metabolites: a cross-sectional study within the EPIC cohort

Metabolite

Variable

Discovery

Validation

P-value

minP P-value

P-value

Bonf. P-value

Arginineb

-

-

-

-

-

Asparagine

BMI

1.4E−19

1.4E−19

9.3E−07

5.6E−06

Waist circumference

4.8E−16

4.8E−16

9.9E−05

6.0E−04

Hip circumference

2.2E−13

2.2E−13

3.7E−03

2.2E−02

Waist/hip ratio

1.3E−05

1.0E−03

8.2E−03

4.9E−02

Fiber intake

1.3E−03

3.9E−02

1.5E−01

8.9E−01

WCRF/AICR score

8.3E−04

2.4E−02

5.0E−01

1.0E+00

C2

Age at blood collection

8.6E−04

2.6E−02

2.3E−04

1.1E−03

Alcohol consumption at recruitment

2.8E−04

8.0E−03

2.0E−01

1.0E+00

Alcohol consumption (lifetime)

8.6E−04

2.6E−02

3.5E−01

1.0E+00

Carbohydrate intake

3.8E−05

1.0E−03

3.0E−01

1.0E+00

Total sugar intake

2.1E−04

6.0E−03

1.1E−01

5.5E−01

PC aa C36:3

Age at blood collection

1.0E−03

4.3E−02

1.2E−01

2.4E−01

BMI

8.9E−04

3.6E−02

6.7E−02

1.3E−01

PC ae C34:2

Smoking status

1.2E−04

1.0E−03

7.5E−01

1.0E+00

Smoking status and intensity

2.0E−04

3.0E−03

8.4E−01

1.0E+00

BMI

5.7E−10

45.7E−10

6.6E−05

7.9E−04

Waist circumference

2.6E−14

2.6E−14

3.0E−07

3.6E−06

Hip circumference

4.3E−05

4.3E−05

2.2E−02

2.6E−01

Waist/hip ratio

5.0E−12

5.0E−12

3.3E−07

3.9E−06

Carbohydrate intake

4.3E−06

4.3E−06

4.2E−02

5.0E−01

Total sugar intake

1.4E−03

3.2E−02

9.8E−01

1.0E+00

Total fat intake

2.2E−09

2.2E−09

1.4E−04

1.7E−03

Fatty acids, total saturated intake

6.8E−10

6.8E−10

8.7E−07

1.0E−05

Fatty acids, total monounsaturated intake

1.5E−04

1.0E−03

1.2E−01

1.0E+00

Modified Mediterranean diet score

5.1E−04

1.5E−02

9.5E−03

1.1E−01

PC ae C36:2

Smoking status

2.1E−04

6.0E−03

6.1E−01

1.0E+00

Smoking status and intensity

2.4E−04

8.0E−03

9.0E−01

1.0E+00

Alcohol consumption at recruitment

4.4E−08

4.4E−08

1.4E−04

1.7E−03

Alcohol consumption (lifetime)

1.3E−06

1.3E−06

6.8E−04

8.1E−03

BMI

4.4E−13

4.4E−13

7.0E−09

8.4E−08

Waist circumference

2.1E−19

2.1E−19

1.8E−12

2.2E−11

Hip circumference

1.1E−07

1.1E−07

7.7E−05

9.3E−04

Waist/hip ratio

9.1E−15

9.1E−15

7.0E−10

8.4E−09

Total fat intake

1.4E−11

1.4E−11

2.1E−05

2.5E−04

Fatty acids, total saturated intake

2.2E−17

2.2E−17

1.6E−10

1.9E−09

Healthy Lifestyle Index

2.8E−05

2.0E−03

2.3E−04

2.8E−03

WCRF/AICR score

3.9E−05

2.0E−03

8.1E−05

9.7E−04

PC ae C36:3

Smoking status

3.8E−04

7.0E−03

8.1E−01

1.0E+00

Smoking status and intensity

1.4E−03

2.8E−02

8.6E−01

1.0E+00

BMI

1.9E−07

1.9E−07

2.2E−03

2.7E−02

Waist circumference

7.2E−12

7.2E−12

7.3E−05

8.8E−04

Hip circumference

4.7E−04

8.0E−03

6.8E−02

8.1E−01

Waist/hip ratio

1.5E−10

1.5E−10

8.2E−05

9.8E−04

Carbohydrate intake

1.9E−04

5.0E−03

2.2E−01

1.0E+00

Total fat intake

8.5E−08

8.5E−08

4.1E−03

4.9E−02

Fatty acids, total saturated intake

1.5E−06

1.5E−06

1.6E−03

2.0E−02

Fatty acids, total monounsaturated intake

2.8E−05

2.8E−05

5.0E−02

6.0E−01

Fatty acids, total trans intake

1.4E−04

3.0E−03

2.1E−01

1.0E+00

Modified Mediterranean diet score

3.0E−04

6.0E−03

5.6E−02

6.7E−01

PC ae C38:2

Alcohol consumption at recruitment

3.4E−04

2.4E−02

1.2E−02

9.9E−02

BMI

6.2E−11

6.2E−11

1.9E−09

1.5E−08

Waist circumference

1.6E−13

1.6E−13

2.5E−11

2.0E−10

Hip circumference

7.6E−08

7.6E−08

1.2E−06

9.6E−06

Waist/hip ratio

1.1E−07

1.1E−07

3.6E−06

2.9E−05

Total fat intake

2.5E−04

1.7E−02

9.2E−03

7.3E−02

Fatty acids, total saturated intake

1.7E−06

1.7E−06

1.2E−04

1.0E−03

Fatty acids, total trans-polyenoic intake

1.2E−03

4.9E−02

6.3E−01

1.0E+00

  1. Bold lines correspond to variable showing significant association after adjustment of P-value for multiple tests in both discovery and validation sets. Models were adjusted for center of recruitment, age, menopausal status (premenopausal, perimenopausal, postmenopausal), phase of the menstrual cycle for premenopausal women (follicular, ovulatory, luteal, missing), time of the day, and fasting status at blood collection (no, in between, yes)
  2. Abbreviations: AICR American Institute for Cancer Research, BMI body mass index, C2 acetylcarnitine, PC aa phosphatidylcholine diacyl, PC ae phosphatidylcholine acyl-alkyl, WCRF World Cancer Research Fund
  3. aOnly associations for which a significant P-value was detected after correction of P-values for multiple tests in the discovery sets are included
  4. bNo association was detected in the discovery set